Huai-feng Li

No. 227 South Chongqing Road
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

RETRACTED: Xiang et al. Schisandrin B Induces Apoptosis and Cell Cycle Arrest of Gallbladder Cancer Cells. Molecules 2014, 19, 13235-13250.

RETRACTED: Xiang et al. Schisandrin B Induces Apoptosis and Cell Cycle Arrest of Gallbladder Cancer Cells. Molecules 2014, 19, 13235-13250.

Journal: Molecules (Basel, Switzerland)

Published: December 03, 2025

Correction: SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.

Correction: SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.

Journal: Molecular cancer

Published: April 01, 2025

Retraction: miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.

Retraction: miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.

Journal: Oncotarget

Published: January 20, 2025

Author Correction: LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis.

Author Correction: LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis.

Journal: EMBO reports

Published: October 04, 2024

Case report: A de novo ERBB3 mutation develops in a gallbladder cancer patient carrying BRCA1 mutation after effective treatment with olaparib.

Case report: A de novo ERBB3 mutation develops in a gallbladder cancer patient carrying BRCA1 mutation after effective treatment with olaparib.

Journal: Frontiers in oncology

Published: October 24, 2022

Improved long-term outcomes after innovative preoperative evaluation and conception of precise surgery for gallbladder cancer.

Improved long-term outcomes after innovative preoperative evaluation and conception of precise surgery for gallbladder cancer.

Journal: Cancer medicine

Published: September 26, 2022

LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis.

LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis.

Journal: EMBO reports

Published: July 04, 2022

Correction to: LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis.

Correction to: LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis.

Journal: Molecular cancer

Published: August 29, 2021

Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit.

Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit.

Journal: Frontiers in oncology

Published: April 08, 2021

Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimen.

Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimen.

Journal: Hepatobiliary surgery and nutrition

Published: December 16, 2020

LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis.

LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis.

Journal: Molecular cancer

Published: June 24, 2019

MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7.

MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7.

Journal: Cell death & disease

Published: November 21, 2017

Showing 1-12 of 28

Last Updated: 09/26/2026